The most important financial indicators for the company Genasmefa Med S.r.l. - Unique Identification Number 40688104:
sales in 2023 was
58.085
euro, registering a net profit of
10.464
euro and having an average number of
2
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 1.4%, from 57.470 euro in the year 2022, to 58.085 euro in 2023.
The Net Profit increased by 592 euro, from 9.902 euro in 2022, to 10.464 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Genasmefa Med S.r.l. - CUI 40688104
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
-
-
-
93
69
47
26
1.058
Current Assets
-
-
-
-
-
4.254
8.275
15.560
17.881
19.590
Inventories
-
-
-
-
-
246
173
79
0
1.280
Receivables
-
-
-
-
-
3.642
3.542
6.918
2.566
11.385
Cash
-
-
-
-
-
367
4.560
8.563
15.315
6.925
Shareholders Funds
-
-
-
-
-
3.379
6.865
12.632
16.170
17.870
Social Capital
-
-
-
-
-
42
41
40
41
40
Debts
-
-
-
-
-
968
1.479
2.975
1.737
2.777
Income in Advance
-
-
-
-
-
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
19.590 euro in 2023 which includes Inventories of
1.280 euro, Receivables of
11.385 euro and cash availability of
6.925 euro.
The company's Equity was valued at
17.870 euro, while total Liabilities amounted to
2.777 euro.
Equity increased by 1.749 euro, from 16.170 euro in 2022, to 17.870 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Genasmefa Med S.r.l.